It is well known there is a race to create effective Covid vaccines, but there is also a race to find better treatments for those that have it. Merck just acquired a treatment that many think could be a game changer.
SOURCE:, an IPO news and data service that predicts the opening-day performances of IPOs
LifeSci has created a second SPAC - here's what they did with the first.